Search Results - "Humes, H"

Refine Results
  1. 1
  2. 2

    Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states by Westover, Angela J., Humes, H. David, Pino, Christopher J.

    Published in Scientific reports (03-06-2024)
    “…Cell directed therapy is an evolving therapeutic approach to treat organ dysfunction arising from hyperinflammation and cytokine storm by processing immune…”
    Get full text
    Journal Article
  3. 3

    Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human by Humes, H David, Aaronson, Keith D, Buffington, Deborah A, Sabbah, Hani N, Westover, Angela J, Yessayan, Lenar T, Szamosfalvi, Balazs, Pagani, Francis D

    Published in PloS one (06-04-2023)
    “…Inflammation has been associated with progression and complications of chronic heart failure (HF) but no effective therapy has yet been identified to treat…”
    Get full text
    Journal Article
  4. 4

    Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes by Kim, Eun Jung, Chen, Caressa, Gologorsky, Rebecca, Santandreu, Ana, Torres, Alonso, Wright, Nathan, Goodin, Mark S., Moyer, Jarrett, Chui, Benjamin W., Blaha, Charles, Brakeman, Paul, Vartanian, Shant, Tang, Qizhi, David Humes, H., Fissell, William H., Roy, Shuvo

    Published in Nature communications (29-08-2023)
    “…The definitive treatment for end-stage renal disease is kidney transplantation, which remains limited by organ availability and post-transplant complications…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A digital protein microarray for COVID-19 cytokine storm monitoring by Song, Yujing, Ye, Yuxuan, Su, Shiuan-Haur, Stephens, Andrew, Cai, Tao, Chung, Meng-Ting, Han, Meilan K, Newstead, Michael W, Yessayan, Lenar, Frame, David, Humes, H David, Singer, Benjamin H, Kurabayashi, Katsuo

    Published in Lab on a chip (21-01-2021)
    “…Despite widespread concern regarding cytokine storms leading to severe morbidity in COVID-19, rapid cytokine assays are not routinely available for monitoring…”
    Get more information
    Journal Article
  7. 7

    Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy by Yessayan, Lenar, Szamosfalvi, Balazs, Napolitano, Lena, Singer, Benjamin, Kurabayashi, Katsuo, Song, Yujing, Westover, Angela, Humes, H. David

    Published in ASAIO journal (1992) (01-11-2020)
    “…Observational evidence suggests that excessive inflammation with cytokine storm may play a critical role in development of acute respiratory distress syndrome…”
    Get full text
    Journal Article
  8. 8

    Estimating Changes in Glomerular Filtration Rate With Fluorescein Isothiocyanate-Sinistrin During Renal Replacement Therapy by Chan, Goldia, Pino, Christopher J., Johnston, Kimberly A., Humes, H. David

    Published in ASAIO journal (1992) (01-08-2023)
    “…Excreted exclusively by the kidneys, fluorescein isothiocyanate (FITC)-sinistrin can be used to measure glomerular filtration rate (GFR) and is detectable…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Extracorporeal Immunomodulation Therapy in Acute Chronic Liver Failure With Multiorgan Failure: First in Human Use by Yessayan, Lenar T, Sharma, Pratima, Westover, Angela J, Szamosfalvi, Balazs, Humes, H David

    Published in ASAIO journal (1992) (01-03-2024)
    “…Two patients presented with acute on chronic liver failure and multiorgan failure and, as typical for this disorder, they presented with hyperinflammation and…”
    Get full text
    Journal Article
  11. 11

    The bioartificial kidney: current status and future promise by Humes, H. David, Buffington, Deborah, Westover, Angela J., Roy, Shuvo, Fissell, William H.

    Published in Pediatric nephrology (Berlin, West) (01-03-2014)
    “…The rapid understanding of the cellular and molecular bases of organ function and disease processes will be translated in the next decade into new therapeutic…”
    Get full text
    Journal Article
  12. 12

    Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure by Goldstein, Stuart L., Yessayan, Lenar T., Krallman, Kelli A., Collins, Michaela, Benoit, Stefanie, Westover, Angela, Humes, H. David

    Published in Pediatric nephrology (Berlin, West) (01-03-2023)
    “…Introduction Hemophagocytic lymphohistiocytosis (HLH) is a dysregulated immune disorder in children, associated with Epstein–Barr virus (EBV) infection or…”
    Get full text
    Journal Article
  13. 13

    Immunomodulatory therapy using a pediatric dialysis system ameliorates septic shock in miniature pigs by Johnston, Kimberly A., Pino, Christopher J., Chan, Goldia, Ketteler, Skylar K., Goldstein, Stuart L., Humes, H. David

    Published in Pediatric research (01-01-2023)
    “…Background Application of the immunomodulatory selective cytopheretic device (SCD) to enhance renal replacement therapy and improve outcomes of acute kidney…”
    Get full text
    Journal Article
  14. 14

    Immunomodulatory Device Promotes a Shift of Circulating Monocytes to a Less Inflammatory Phenotype in Chronic Hemodialysis Patients by Szamosfalvi, Balazs, Westover, Angela, Buffington, Deborah, Yevzlin, Alexander, Humes, H David

    Published in ASAIO journal (1992) (01-09-2016)
    “…Patients with end-stage renal disease (ESRD) on chronic hemodialysis (HD) suffer accelerated morbidity and mortality rates caused by cardiovascular disease and…”
    Get full text
    Journal Article
  15. 15

    In vivo Assessment of a Manual Single Lumen Alternating Micro-Batch Hemodiafiltration System by Lanker, Sabrina L, Pino, Christopher J, Humes, H David, Chawla, Lakhmir, Johnston, Kimberly A

    Published in Blood purification (2024)
    “…The manual single lumen alternating micro-batch hemodiafiltration (mSLAMB) system is a closed-loop dialysis system designed to provide kidney support in…”
    Get more information
    Journal Article
  16. 16

    A microfluidic bioreactor with integrated transepithelial electrical resistance (TEER) measurement electrodes for evaluation of renal epithelial cells by Ferrell, Nicholas, Desai, Ravi R., Fleischman, Aaron J., Roy, Shuvo, Humes, H. David, Fissell, William H.

    Published in Biotechnology and bioengineering (01-11-2010)
    “…We have developed a bilayer microfluidic system with integrated transepithelial electrical resistance (TEER) measurement electrodes to evaluate kidney…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The future of hemodialysis membranes by Humes, H.D., Fissell, W.H., Tiranathanagul, K.

    Published in Kidney international (01-04-2006)
    “…Hemodialytic treatment of patients with either acute or chronic renal failure has had a dramatic impact on the mortality rates of these patients…”
    Get full text
    Journal Article
  19. 19

    Efficacy and Safety of Renal Tubule Cell Therapy for Acute Renal Failure by TUMLIN, James, WALI, Ravinder, FINKEL, Kevin W, KRAUS, Michael A, HUMES, H. David, WILLIAMS, Winfred, MURRAY, Patrick, TOLWANI, Ashita J, VINNIKOVA, Anna K, SZERLIP, Harold M, JIUMING YE, PAGANINI, Emil P, DWORKIN, Lance

    “…The mortality rate for patients with acute renal failure (ARF) remains unacceptably high. Although dialysis removes waste products and corrects fluid…”
    Get full text
    Journal Article
  20. 20

    Novel Leukocyte Modulator Device Reduces the Inflammatory Response to Cardiopulmonary Bypass by Johnston, Kimberly A, Westover, Angela J, Rojas-Pena, Alvaro, Haft, Jonathan W, Toomasian, John M, Johnson, Thomas, Buffington, Deborah A, Humes, H David

    Published in ASAIO journal (1992) (01-05-2019)
    “…Leukocyte (LE) activation during cardiopulmonary bypass (CPB) promotes a systemic inflammatory response that contributes to organ injury and postoperative…”
    Get full text
    Journal Article